Skip to content
PubMed This is a summary of 45 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 45 referenced papers

Top Authors

Alexander Grimm
Hertie Institute for Clinical Brain Research
Marinos C. Dalakas
National Institutes of Health
Yusuf A. Rajabally
Aston University
Bernd C. Kieseier
Heinrich Heine University Düsseldorf
Eduardo Nobile‐Orazio
Fondazione Humanitas per la Ricerca
W. Ludo van der Pol
Hersenstichting
Hubertus Axer
Jena University Hospital
Hans‐Peter Hartung
University of Graz
Michael P. Lunn
National Hospital for Neurology and Neurosurgery
Luís Querol
Hospital de Sant Pau

Top Institutions

Ranked by publications Top 10 institutions

References

References (45)
  1. 1

    Outcome measures in MMN revisited: further improvement needed.

    Pruppers MH, Draak TH, Vanhoutte EK, et al.

    Journal of the peripheral nervous system : JPNS 2015; (20(3)):306-18 doi:10.1111/jns.12124.

    PMID: 26115442
  2. 2

    Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).

    Vanhoutte EK, Faber CG, van Nes SI, et al.

    Journal of the peripheral nervous system : JPNS 2015; (20(3)):296-305 doi:10.1111/jns.12141.

    PMID: 26329270
  3. 3

    Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).

    Loewenbrück KF, Liesenberg J, Dittrich M, et al.

    Journal of neurology 2016; (263(1)):35-44 doi:10.1007/s00415-015-7927-9.

    PMID: 26477025
  4. 4

    Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy.

    Katzberg HD, Rasutis V, Bril V

    Muscle & nerve 2016; (54(5)):856-863 doi:10.1002/mus.25107.

    PMID: 26991654
  5. 5

    Cervical root sonography to differentiate multifocal motor neuropathy from ALS.

    Nodera H, Izumi Y, Takamatsu N, Kaji R

    The journal of medical investigation : JMI 2016; (63(1-2)):104-7 doi:10.2152/jmi.63.104.

    PMID: 27040062
  6. 6

    [Clinical and electrophysiological characteristics and therapeutic analysis of 9 patients with Lewis-Sumner syndrome].

    Sun A, Zhang Y, Liu X, et al.

    Zhonghua yi xue za zhi 2016; (96(11)):859-62 doi:10.3760/cma.j.issn.0376-2491.2016.11.007.

    PMID: 27045647
  7. 7

    Comparative study of peripheral nerve Mri and ultrasound in multifocal motor neuropathy and amyotrophic lateral sclerosis.

    Jongbloed BA, Haakma W, Goedee HS, et al.

    Muscle & nerve 2016; (54(6)):1133-1135 doi:10.1002/mus.25391.

    PMID: 27571543
  8. 8

    Immunoglobulin therapy in the treatment of multifocal motor neuropathy.

    Kumar A, Patwa HS, Nowak RJ

    Journal of the neurological sciences 2017; (375()):190-197 doi:10.1016/j.jns.2017.01.061.

    PMID: 28320129
  9. 9

    Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.

    Nobile-Orazio E, Gallia F, Terenghi F, Bianco M

    Expert review of neurotherapeutics 2017; (17(8)):755-765 doi:10.1080/14737175.2017.1340832.

    PMID: 28597710
  10. 10

    Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy.

    Rattay TW, Winter N, Décard BF, et al.

    European journal of neurology 2017; (24(9)):1125-1134 doi:10.1111/ene.13344.

    PMID: 28681489
  11. 11

    A look inside the nerve - Morphology of nerve fascicles in healthy controls and patients with polyneuropathy.

    Grimm A, Winter N, Rattay TW, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2017; (128(12)):2521-2526 doi:10.1016/j.clinph.2017.08.022.

    PMID: 28958781
  12. 12

    Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies - Current concepts and future directions.

    Décard BF, Pham M, Grimm A

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2018; (129(1)):155-167 doi:10.1016/j.clinph.2017.10.028.

    PMID: 29190522
  13. 13

    Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.

    Le Masson G, Solé G, Desnuelle C, et al.

    Brain and behavior 2018; (8(2)):e00923 doi:10.1002/brb3.923.

    PMID: 29484273
  14. 14

    Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment.

    Löscher WN, Oberreiter EM, Erdler M, et al.

    Journal of neurology 2018; (265(12)):2834-2840 doi:10.1007/s00415-018-9071-9.

    PMID: 30259176
  15. 15

    Immune-mediated neuropathies.

    Kieseier BC, Mathey EK, Sommer C, Hartung HP

    Nature reviews. Disease primers 2018; (4(1)):31 doi:10.1038/s41572-018-0027-2.

    PMID: 30310069
  16. 16

    A population-based and cross-sectional study of the long-term prognosis in multifocal motor neuropathy.

    Al-Zuhairy A, Sindrup SH, Andersen H, Jakobsen J

    Journal of the peripheral nervous system : JPNS 2019; (24(1)):64-71 doi:10.1111/jns.12311.

    PMID: 30746851
  17. 17

    Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography.

    Kronlage M, Knop KC, Schwarz D, et al.

    Radiology 2019; (292(1)):149-156 doi:10.1148/radiol.2019182538.

    PMID: 31063079
  18. 18

    Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy.

    Herraets IJT, Bakers JNE, van Eijk RPA, et al.

    Journal of neurology 2019; (266(11)):2734-2742 doi:10.1007/s00415-019-09475-x.

    PMID: 31325017
  19. 19

    Conduction Block and Nerve Cross-Sectional Area in Multifocal Motor Neuropathy.

    Li Y, Niu J, Liu T, et al.

    Frontiers in neurology 2019; (10()):1055 doi:10.3389/fneur.2019.01055.

    PMID: 31649606
  20. 20

    Low interrater reliability of brachial plexus MRI in chronic inflammatory neuropathies.

    van Rosmalen MHJ, Goedee HS, van der Gijp A, et al.

    Muscle & nerve 2020; (61(6)):779-783 doi:10.1002/mus.26821.

    PMID: 32012299
  21. 21

    Difference in distribution of fasciculations between multifocal motor neuropathy and amyotrophic lateral sclerosis.

    Tsuji Y, Noto YI, Kitaoji T, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2020; (131(12)):2804-2808 doi:10.1016/j.clinph.2020.08.021.

    PMID: 33137570
  22. 22

    Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome.

    Pro S, Ursitti F, Pruneddu GL, et al.

    Neuropediatrics 2021; (52(5)):406-409 doi:10.1055/s-0040-1722677.

    PMID: 33511596
  23. 23

    Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.

    Gentile L, Russo M, Rodolico C, et al.

    Scientific reports 2021; (11(1)):9216 doi:10.1038/s41598-021-88711-9.

    PMID: 33911162
  24. 24

    Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.

    Budding K, Johansen LE, Van de Walle I, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2022; (9(1)) doi:10.1212/NXI.0000000000001107.

    PMID: 34759020
  25. 25

    A Case of Probable Multifocal Motor Neuropathy With Clinical Stability for Ten Years After a Single Treatment of Rituximab.

    Gonzalez NL, Juel VC, Živković SA

    Journal of clinical neuromuscular disease 2022; (23(3)):136-142 doi:10.1097/CND.0000000000000358.

    PMID: 35188910
  26. 26

    Multifocal Motor Neuropathy With Cranial Nerve Involvement and Vocal Cord Paralysis: A Case Report.

    Nunez MC, Nepomuceno BLM, Tiongson MLGP

    Cureus 2022; (14(5)):e25179 doi:10.7759/cureus.25179.

    PMID: 35746993
  27. 27

    Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia.

    Park SB, Li T, Kiernan MC, et al.

    Muscle & nerve 2022; (66(5)):576-582 doi:10.1002/mus.27698.

    PMID: 36054471
  28. 28

    Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.

    Dziadkowiak E, Nowakowska-Kotas M, Rałowska-Gmoch W, et al.

    International journal of molecular sciences 2023; (24(11)) doi:10.3390/ijms24119180.

    PMID: 37298132
  29. 29

    Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.

    Tavee J, Brannagan TH, Lenihan MW, et al.

    Muscle & nerve 2023; (68(4)):356-374 doi:10.1002/mus.27922.

    PMID: 37432872
  30. 30

    A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy.

    Allen JA, Clarke AE, Harbo T

    Mayo Clinic proceedings. Innovations, quality & outcomes 2024; (8(1)):74-81 doi:10.1016/j.mayocpiqo.2023.12.002.

    PMID: 38283096
  31. 31

    IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset.

    Budding K, Bos JW, Dijkxhoorn K, et al.

    Journal of neuroinflammation 2024; (21(1)):100 doi:10.1186/s12974-024-03090-y.

    PMID: 38632654
  32. 32

    Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy.

    Al-Zuhairy A, Jakobsen J, Krarup C

    European journal of neurology 2024; (31(7)):e16305 doi:10.1111/ene.16305.

    PMID: 38651498
  33. 33

    Dose-exposure-efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy.

    Li Z, Roepcke S, Franke R, Yel L

    Annals of clinical and translational neurology 2024; (11(8)):1977-1987 doi:10.1002/acn3.52098.

    PMID: 38978354
  34. 34

    Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy.

    Doneddu PE, Gallo C, Gentile L, et al.

    European journal of neurology 2024; (31(12)):e16444 doi:10.1111/ene.16444.

    PMID: 39236307
  35. 35

    Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment.

    Aotsuka Y, Misawa S, Suichi T, et al.

    Muscle & nerve 2024; (70(5)):1027-1033 doi:10.1002/mus.28251.

    PMID: 39253889
  36. 36

    Dose, exposure, and treatment regimen of intravenous immunoglobulin G in multifocal motor neuropathy.

    Li Z, Roepcke S, Franke R, Yel L

    Frontiers in neurology 2024; (15()):1478419 doi:10.3389/fneur.2024.1478419.

    PMID: 39574508
  37. 37

    Multifocal Motor Neuropathy: A Narrative Review.

    Claytor B, Polston D, Li Y

    Muscle & nerve 2025; (71(4)):512-534 doi:10.1002/mus.28349.

    PMID: 39936246
  38. 38

    Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey.

    Rajabally YA, Englezou C, Cluett G, et al.

    Journal of the peripheral nervous system : JPNS 2025; (30(2)):e70018 doi:10.1111/jns.70018.

    PMID: 40210218
  39. 39

    Efficacy of Subcutaneous and Intravenous Immunoglobulin in Patients with Multifocal Motor Neuropathy: A Systematic Review and Meta-analysis.

    Sharawat IK, Panda P, Dawman L, et al.

    Annals of Indian Academy of Neurology 2025; (28(4)):485-494 doi:10.4103/aian.aian_815_24.

    PMID: 40265739
  40. 40

    Radial motor nerve conduction study in posterior interosseous nerve syndrome and multifocal motor neuropathy.

    Baima JPS, Heise CO

    Arquivos de neuro-psiquiatria 2025; (83(2)):1-5 doi:10.1055/s-0045-1806818.

    PMID: 40288409
  41. 41

    Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy.

    Doneddu PE, Gallo C, Falzone Y, et al.

    European journal of neurology 2025; (32(9)):e70300 doi:10.1111/ene.70300.

    PMID: 40984777
  42. 42

    Variably Defined Conduction Block, Temporal Dispersion and Other Electrophysiological Abnormalities in Multifocal Motor Neuropathy: A Multicentre Study.

    Rajabally YA, Min YG, Al-Areed A, et al.

    European journal of neurology 2025; (32(10)):e70361 doi:10.1111/ene.70361.

    PMID: 41037424
  43. 43

    IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

    Krijgsman D, Dijkxhoorn K, de Zeeuw E, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2026; (13(1)):e200482 doi:10.1212/NXI.0000000000200482.

    PMID: 41223338
  44. 44

    Immunotherapies in chronic immune-mediated neuropathies.

    Briani C, Visentin A

    Handbook of clinical neurology 2026; (214()):345-356 doi:10.1016/B978-0-323-90887-0.00019-5.

    PMID: 41526145
  45. 45

    The Potential Misdiagnosis of Multifocal Motor Neuropathy as Amyotrophic Lateral Sclerosis-A Case Series.

    Lawson V, Robbins NM

    US neurology 2018; (14(2)):102-107 doi:10.17925/usn.2018.14.2.102.

    PMID: 41583971